Balance Sheet Dover Corporation

Stocks

DOV

US2600031080

Industrial Machinery & Equipment

Real-time Estimate Cboe BZX Other stock markets 12:09:35 21/07/2026 am IST			5-day change	1st Jan Change
210.18 ^USD	-1.87%		-2.15%	+7.39%

16/07	CPC Biotech, Part of PSG and Dover Launches RevolveSD Series One-Inch Single-Use Sterile Disconnect for Bioprocessing	CI
10/07	Goldman Sachs Adjusts Price Target on Dover to $255 From $263	MT

19654ebb607b40fc85b376.1WgWHoq7euvG-noJ7C-l0Hp29Q58eZAY_xQSEdmCI5U.nwR7RuL2MJucvxtEjmiV5zNboEQ1LtZgpnpaRobUZ-KNK3EzzNIcpLG7Lw

Published financial data: DOVER CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	790.71Cr	850.81Cr	843.81Cr	774.59Cr	809.26Cr
Total Revenues	790.71Cr	850.81Cr	843.81Cr	774.59Cr	809.26Cr
Cost of Goods Sold, Total	492.44Cr	543.77Cr	533.41Cr	474.93Cr	484.23Cr
Gross Profit	298.27Cr	307.04Cr	310.4Cr	299.66Cr	325.03Cr
Selling General & Admin Expenses, Total	151.4Cr	149.02Cr	153.22Cr	155.6Cr	164.01Cr
R&D Expenses	16Cr	16Cr	15Cr	15Cr	17Cr
Other Operating Expenses, Total	167.18Cr	165.35Cr	168.53Cr	170.56Cr	180.54Cr
Operating Income	131.09Cr	141.69Cr	141.86Cr	129.1Cr	144.49Cr
Interest Expense, Total	-11Cr	-12Cr	-13Cr	-13Cr	-11Cr
Interest And Investment Income	44.41L	44.3L	1.35Cr	3.72Cr	7.3Cr
Net Interest Expenses	-10Cr	-11Cr	-12Cr	-9.4Cr	-3.67Cr
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	2.43Cr	1.31Cr	1.96Cr	3.21Cr	1.82Cr
EBT, Excl. Unusual Items	123.33Cr	131.8Cr	132.04Cr	122.9Cr	142.64Cr
Restructuring Charges	-2.67Cr	-3.05Cr	-5.04Cr	-6.98Cr	-5.67Cr
Gain (Loss) On Sale Of Investments	-1.21Cr	-	-	-	-
Gain (Loss) On Sale Of Assets	21Cr	-	-	60Cr	46.44L
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	140.08Cr	128.75Cr	127Cr	175.7Cr	137.43Cr
Income Tax Expense	28Cr	22Cr	21Cr	36Cr	28Cr
Earnings From Continuing Operations	112.38Cr	106.54Cr	105.68Cr	140Cr	109.74Cr
Earnings Of Discontinued Operations	-	-	-	129.72Cr	-34.73L
Net Income to Company	112.38Cr	106.54Cr	105.68Cr	269.71Cr	109.4Cr
Net Income - (IS)	112.38Cr	106.54Cr	105.68Cr	269.71Cr	109.4Cr
Net Income to Common Incl Extra Items	112.38Cr	106.54Cr	105.68Cr	269.71Cr	109.4Cr
Net Income to Common Excl. Extra Items	112.38Cr	106.54Cr	105.68Cr	140Cr	109.74Cr
Per Share Items
Net EPS - Basic	7.81	7.47	7.56	19.58	7.99
Basic EPS - Continuing Operations	7.81	7.47	7.56	10.16	8.01
Basic Weighted Average Shares Outstanding	14Cr	14Cr	14Cr	14Cr	14Cr
Net EPS - Diluted	7.74	7.42	7.52	19.44	7.94
Diluted EPS - Continuing Operations	7.74	7.42	7.52	10.09	7.97
Diluted Weighted Average Shares Outstanding	15Cr	14Cr	14Cr	14Cr	14Cr
Normalized Basic EPS	5.36	5.77	5.9	5.58	6.51
Normalized Diluted EPS	5.31	5.74	5.87	5.54	6.47
Dividend Per Share	1.99	2.01	2.03	2.05	2.07
Payout Ratio	25.53	26.99	26.9	10.5	25.87
Supplemental Items
EBITDA	160.1Cr	172.45Cr	173.61Cr	162.88Cr	182.44Cr
EBITA	145.37Cr	157.56Cr	157.88Cr	147.44Cr	165.52Cr
EBIT	131.09Cr	141.69Cr	141.86Cr	129.1Cr	144.49Cr
EBITDAR	167.96Cr	180.75Cr	182.55Cr	171.97Cr	192.23Cr
Effective Tax Rate - (Ratio)	19.77	17.25	16.79	20.32	20.14
Current Domestic Taxes	18Cr	11Cr	16Cr	28Cr	15Cr
Current Foreign Taxes	15Cr	14Cr	14Cr	17Cr	16Cr
Total Current Taxes	33Cr	25Cr	31Cr	45Cr	31Cr
Deferred Domestic Taxes	-1.1Cr	-44.57L	-2.44Cr	-4.77Cr	-72.35L
Deferred Foreign Taxes	-4.53Cr	-2.23Cr	-6.78Cr	-4.4Cr	-2.14Cr
Total Deferred Taxes	-5.62Cr	-2.68Cr	-9.22Cr	-9.16Cr	-2.86Cr
Normalized Net Income	77Cr	82Cr	83Cr	77Cr	89Cr
Non-Cash Pension Expense	-26.91L	-71.27L	-18.7L	-1.48Cr	-1.48Cr
Supplemental Operating Expense Items
Advertising Expense	2.37Cr	2.59Cr	2.39Cr	2.32Cr	2.38Cr
Selling and Marketing Expenses	2.37Cr	2.59Cr	2.39Cr	2.32Cr	2.38Cr
Research And Development Expense From Footnotes	16Cr	16Cr	15Cr	15Cr	17Cr
Net Rental Expense, Total	7.85Cr	8.3Cr	8.94Cr	9.09Cr	9.78Cr
Imputed Operating Lease Interest Expense	2.02Cr	2.15Cr	2.48Cr	2.79Cr	2.55Cr
Imputed Operating Lease Depreciation	5.83Cr	6.16Cr	6.46Cr	6.31Cr	7.24Cr
Stock-Based Comp., SG&A Exp. (Total)	3.11Cr	3.08Cr	3.15Cr	4.04Cr	4.4Cr
Total Stock-Based Compensation	3.11Cr	3.08Cr	3.15Cr	4.04Cr	4.4Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	39Cr	38Cr	40Cr	184.49Cr	167.68Cr
Total Cash And Short Term Investments	39Cr	38Cr	40Cr	184.49Cr	167.68Cr
Accounts Receivable, Total	135.9Cr	152.79Cr	145.16Cr	137.66Cr	140.74Cr
Total Receivables	135.9Cr	152.79Cr	145.16Cr	137.66Cr	140.74Cr
Inventory	119.11Cr	136.66Cr	122.55Cr	114.48Cr	127.28Cr
Prepaid Expenses	12Cr	15Cr	12Cr	12Cr	15Cr
Other Current Assets, Total	28.25L	9L	19Cr	22.58L	6L
Total Current Assets	306.17Cr	342.35Cr	339.02Cr	448.45Cr	450.69Cr
Gross Property Plant And Equipment	263.15Cr	277.56Cr	286.13Cr	284.22Cr	317.36Cr
Accumulated Depreciation	-150.51Cr	-157.37Cr	-161.98Cr	-164.59Cr	-182.49Cr
Net Property Plant And Equipment	112.63Cr	120.19Cr	124.15Cr	119.63Cr	134.86Cr
Goodwill	455.88Cr	466.95Cr	488.17Cr	490.57Cr	543Cr
Other Intangibles, Total	135.95Cr	133.37Cr	148.39Cr	158.09Cr	175.96Cr
Deferred Tax Assets Long-Term	3.31Cr	3.57Cr	11Cr	12Cr	13Cr
Other Long-Term Assets, Total	26Cr	23Cr	24Cr	23Cr	25Cr
Total Assets	1.04TCr	1.09TCr	1.13TCr	1.25TCr	1.34TCr
Liabilities
Accounts Payable, Total	107.36Cr	106.81Cr	96Cr	85Cr	88Cr
Accrued Expenses, Total	63Cr	58Cr	56Cr	61Cr	61Cr
Short-term Borrowings	11Cr	74Cr	47Cr	6L	-
Current Portion of Long-Term Debt	-	-	-	40Cr	71Cr
Current Portion of Leases	4.56Cr	4.52Cr	5.19Cr	5.32Cr	5.69Cr
Current Income Taxes Payable	9.2Cr	3.14Cr	3.69Cr	3.42Cr	6.07Cr
Unearned Revenue Current, Total	23Cr	26Cr	21Cr	20Cr	16Cr
Other Current Liabilities	7.3Cr	5.79Cr	13Cr	5.5Cr	5.68Cr
Total Current Liabilities	225.03Cr	277.33Cr	241.38Cr	219.65Cr	251.85Cr
Long-Term Debt	301.87Cr	294.25Cr	299.18Cr	252.93Cr	262.13Cr
Long-Term Leases	14Cr	17Cr	18Cr	18Cr	20Cr
Unearned Revenue Non Current	2.15Cr	1.99Cr	1.95Cr	44.52L	44.27L
Pension & Other Post Retirement Benefits	14Cr	9.26Cr	8.61Cr	8.7Cr	8.4Cr
Deferred Tax Liability Non Current	36Cr	38Cr	35Cr	35Cr	39Cr
Other Non Current Liabilities	28Cr	23Cr	21Cr	21Cr	20Cr
Total Liabilities	621.41Cr	661.02Cr	624.19Cr	555.52Cr	601.72Cr
Common Stock, Total	26Cr	26Cr	26Cr	26Cr	26Cr
Additional Paid In Capital	86Cr	87Cr	89Cr	89Cr	85Cr
Retained Earnings	944.52Cr	1.02TCr	1.1TCr	1.34TCr	1.42TCr
Treasury Stock	-621.88Cr	-679.77Cr	-679.77Cr	-728.06Cr	-775.14Cr
Comprehensive Income and Other	-15Cr	-27Cr	-24Cr	-33Cr	-17Cr
Total Common Equity	418.95Cr	428.64Cr	510.66Cr	695.4Cr	740.52Cr
Total Equity	418.95Cr	428.64Cr	510.66Cr	695.4Cr	740.52Cr
Total Liabilities And Equity	1.04TCr	1.09TCr	1.13TCr	1.25TCr	1.34TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	14Cr	14Cr	14Cr	14Cr	13Cr
ECS Total Common Shares Outstanding	14Cr	14Cr	14Cr	14Cr	13Cr
Book Value / Share	29.08	30.68	36.5	50.68	54.92
Tangible Book Value	-172.88Cr	-171.69Cr	-125.9Cr	47Cr	22Cr
Tangible Book Value Per Share	-12	-12.29	-9	3.41	1.6
Total Debt	331.12Cr	389.54Cr	369.08Cr	316.31Cr	358.45Cr
Net Debt	292.57Cr	351.46Cr	329.22Cr	131.82Cr	190.76Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	4.32Cr	2.08Cr	3.02Cr	70.33L	-1.6Cr
Debt Equivalent Oper. Leases	63Cr	66Cr	72Cr	73Cr	78Cr
Account Code - Inventory Valuation	5	5	5	5	5
LIFO Reserve, Total	-1.32Cr	-1.42Cr	-	-	-
Inventories - Raw Materials, Total	67Cr	81Cr	70Cr	65Cr	77Cr
Inventories - Work In Process, Total	27Cr	23Cr	22Cr	23Cr	24Cr
Inventories - Finished Goods, Total	38Cr	46Cr	43Cr	39Cr	42Cr
Land - (BS)	6.37Cr	6.25Cr	6.64Cr	6.23Cr	6.86Cr
Buildings, Total	58Cr	62Cr	64Cr	63Cr	71Cr
Machinery, Total	181.65Cr	189.55Cr	194.45Cr	194.55Cr	217.01Cr
Full Time Employees	25T	25T	25T	24T	24T
Accumulated Allowance for Doubtful Accounts (Supple)	4.01Cr	3.94Cr	3.15Cr	2.88Cr	3.54Cr
Order Backlog	324.42Cr	302.02Cr	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	112.38Cr	106.54Cr	105.68Cr	269.71Cr	109.4Cr
Depreciation & Amortization - CF	15Cr	15Cr	16Cr	15Cr	17Cr
Amortization of Goodwill and Intangible Assets - (CF)	14Cr	16Cr	16Cr	18Cr	21Cr
Depreciation & Amortization, Total	29Cr	31Cr	32Cr	34Cr	38Cr
(Gain) Loss From Sale Of Asset	-21Cr	-	-	-53Cr	-46.44L
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-6.74Cr	-
Stock-Based Compensation (CF)	3.11Cr	3.08Cr	3.15Cr	4.04Cr	4.4Cr
Provision and Write-off of Bad Debts	50.53L	55.52L	28.81L	53.29L	88.19L
Net Cash From Discontinued Operations	-	-	-	-34Cr	-44.3L
Other Operating Activities, Total	-4.38Cr	-4.33Cr	-11Cr	-136.95Cr	-4.83Cr
Change In Accounts Receivable	-20Cr	-21Cr	8.65Cr	-4.39Cr	4.94Cr
Change In Inventories	-30Cr	-20Cr	15Cr	44.18L	-3.72Cr
Change In Accounts Payable	23Cr	1.54Cr	-10Cr	90.76L	-1.56Cr
Change In Income Taxes	8.82Cr	-6.24Cr	-1.68Cr	-2.32Cr	-1.2Cr
Change in Other Net Operating Assets	9.75Cr	-11Cr	-7.69Cr	2.81Cr	-12Cr
Cash from Operations	111.59Cr	81Cr	133.63Cr	75Cr	133.36Cr
Capital Expenditure	-17Cr	-22Cr	-19Cr	-17Cr	-22Cr
Sale of Property, Plant, and Equipment	70.7L	60.61L	42.34L	-	-
Cash Acquisitions	-111.21Cr	-31Cr	-53Cr	-64Cr	-66Cr
Divestitures	27Cr	-	-	77Cr	59.98L
Other Investing Activities, Total	87.35L	-1.32Cr	-46.49L	199.26Cr	-1.89Cr
Cash from Investing	-99Cr	-54Cr	-73Cr	195.87Cr	-90Cr
Short Term Debt Issued, Total	10Cr	63Cr	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	63Cr
Total Debt Issued	10Cr	63Cr	-	-	63Cr
Short Term Debt Repaid, Total	-	-	-27Cr	-47Cr	-6L
Long-Term Debt Repaid, Total	-	-	-	-	-40Cr
Total Debt Repaid	-	-	-27Cr	-47Cr	-40Cr
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-6.36Cr	-60Cr	-1.21Cr	-52Cr	-56Cr
Common Dividends Paid	-29Cr	-29Cr	-28Cr	-28Cr	-28Cr
Common & Preferred Stock Dividends Paid	-29Cr	-29Cr	-28Cr	-28Cr	-28Cr
Other Financing Activities, Total	-44.23L	-29.68L	-41.32L	-43.16L	-1.68Cr
Cash from Financing	-25Cr	-26Cr	-57Cr	-127.17Cr	-62Cr
Foreign Exchange Rate Adjustments	-8L	-91.71L	-66.66L	-63.48L	1.96Cr
Net Change in Cash	-13Cr	-46.36L	3.5Cr	142.9Cr	-17Cr
Supplemental Items
Cash Interest Paid	10Cr	11Cr	13Cr	13Cr	10Cr
Cash Income Tax Paid (Refund)	23Cr	35Cr	33Cr	91Cr	31Cr
Levered Free Cash Flow	74Cr	46Cr	91Cr	113.64Cr	86Cr
Unlevered Free Cash Flow	81Cr	53Cr	100Cr	121.84Cr	93Cr
Change In Net Working Capital	16Cr	47Cr	4.77Cr	-20Cr	18Cr
Net Debt Issued / Repaid	10Cr	63Cr	-27Cr	-47Cr	23Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.38	8.32	7.97	6.76	6.96
Return on Total Capital	11.55	11.29	10.44	8.53	8.56
Return On Equity %	29.67	25.14	22.5	23.22	15.29
Return on Common Equity	29.67	25.14	22.5	23.22	15.29
Margin Analysis
Gross Profit Margin %	37.72	36.09	36.79	38.69	40.16
SG&A Margin	19.15	17.51	18.16	20.09	20.27
EBITDA Margin %	20.25	20.27	20.57	21.03	22.54
EBITA Margin %	18.38	18.52	18.71	19.03	20.45
EBIT Margin %	16.58	16.65	16.81	16.67	17.85
Income From Continuing Operations Margin %	14.21	12.52	12.52	18.07	13.56
Net Income Margin %	14.21	12.52	12.52	34.82	13.52
Net Avail. For Common Margin %	14.21	12.52	12.52	18.07	13.56
Normalized Net Income Margin	9.75	9.68	9.78	9.92	11.02
Levered Free Cash Flow Margin	9.41	5.37	10.82	14.67	10.61
Unlevered Free Cash Flow Margin	10.25	6.23	11.79	15.73	11.46
Asset Turnover
Asset Turnover	0.81	0.8	0.76	0.65	0.62
Fixed Assets Turnover	7.21	7.31	6.91	6.5	6.36
Receivables Turnover (Average Receivables)	6.3	5.89	5.66	5.7	5.81
Inventory Turnover (Average Inventory)	4.86	4.25	4.12	4.15	4.01
Short Term Liquidity
Current Ratio	1.36	1.23	1.4	2.04	1.79
Quick Ratio	0.78	0.69	0.77	1.47	1.22
Operating Cash Flow to Current Liabilities	0.5	0.29	0.55	0.34	0.53
Days Sales Outstanding (Average Receivables)	57.96	61.92	64.44	64.2	62.78
Days Outstanding Inventory (Average Inventory)	75.12	85.84	88.68	88.2	91.12
Average Days Payable Outstanding	66.63	69.63	71.22	65.59	63.29
Cash Conversion Cycle (Average Days)	66.45	78.13	81.9	86.8	90.61
Long Term Solvency
Total Debt/Equity	79.03	90.88	72.27	45.49	48.4
Total Debt / Total Capital	44.14	47.61	41.95	31.26	32.62
LT Debt/Equity	75.42	72.66	62.09	38.97	38.09
Long-Term Debt / Total Capital	42.13	38.07	36.04	26.78	25.67
Total Liabilities / Total Assets	59.73	60.66	55	44.41	44.83
EBIT / Interest Expense	12.33	12.17	10.8	9.84	13.16
EBITDA / Interest Expense	15.8	15.52	13.9	13.11	17.51
(EBITDA - Capex) / Interest Expense	14.18	13.62	12.44	11.83	15.5
Total Debt / EBITDA	1.97	2.16	2.02	1.84	1.86
Net Debt / EBITDA	1.74	1.94	1.8	0.77	0.99
Total Debt / (EBITDA - Capex)	2.2	2.46	2.26	2.04	2.11
Net Debt / (EBITDA - Capex)	1.94	2.22	2.02	0.85	1.12
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.3	7.6	-0.82	0.8	4.48
Gross Profit, 1 Yr. Growth %	19.65	2.94	1.09	3.8	8.46
EBITDA, 1 Yr. Growth %	26.77	7.71	0.67	3.34	12.01
EBITA, 1 Yr. Growth %	29.46	8.38	0.2	3.47	12.27
EBIT, 1 Yr. Growth %	33.24	8.09	0.12	1.56	11.92
Earnings From Cont. Operations, 1 Yr. Growth %	64.43	-5.2	-0.8	48.32	-21.61
Net Income, 1 Yr. Growth %	64.43	-5.2	-0.8	155.21	-59.44
Normalized Net Income, 1 Yr. Growth %	39.99	6.87	0.19	4.79	16.06
Diluted EPS Before Extra, 1 Yr. Growth %	64.68	-4.13	1.35	50.37	-21.01
Accounts Receivable, 1 Yr. Growth %	17.94	12.44	-5	2.68	2.23
Inventory, 1 Yr. Growth %	42.51	14.74	-10.33	0.07	11.18
Net Property, Plant and Equip., 1 Yr. Growth %	5.52	6.71	3.3	0.93	12.73
Total Assets, 1 Yr. Growth %	13.68	4.74	4.15	10.23	7.3
Tangible Book Value, 1 Yr. Growth %	-2.36	-0.69	-26.67	-147.89	-53.89
Common Equity, 1 Yr. Growth %	23.74	2.31	19.14	36.18	6.49
Cash From Operations, 1 Yr. Growth %	1	-27.79	65.86	-44	78.2
Capital Expenditures, 1 Yr. Growth %	3.48	28.87	-12.84	-8.65	31.47
Levered Free Cash Flow, 1 Yr. Growth %	-6.49	-38.6	99.81	38.95	-24.42
Unlevered Free Cash Flow, 1 Yr. Growth %	-6.37	-34.65	87.85	35.39	-23.88
Dividend Per Share, 1 Yr. Growth %	1.02	1	1	0.99	0.98
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.26	12.82	3.3	-0.63	2.62
Gross Profit, 2 Yr. CAGR %	6.5	10.98	2.01	1.45	6.11
EBITDA, 2 Yr. CAGR %	9.72	16.85	4.13	0.49	7.59
EBITA, 2 Yr. CAGR %	10.22	18.45	4.21	0.18	7.78
EBIT, 2 Yr. CAGR %	11.33	20.01	4.03	-1	6.62
Earnings From Cont. Operations, 2 Yr. CAGR %	28.75	24.85	-3.03	18.92	7.83
Net Income, 2 Yr. CAGR %	28.75	24.85	-3.03	59.11	1.74
Normalized Net Income, 2 Yr. CAGR %	14.52	22.31	3.98	0.34	10.28
Diluted EPS Before Extra, 2 Yr. CAGR %	29.57	25.65	-1.43	21.01	8.99
Accounts Receivable, 2 Yr. CAGR %	5.02	15.15	3.35	-5.08	2.46
Inventory, 2 Yr. CAGR %	21.55	27.87	1.43	-8.47	5.47
Net Property, Plant and Equip., 2 Yr. CAGR %	6.27	6.11	4.99	-0.23	6.67
Total Assets, 2 Yr. CAGR %	9.55	9.11	4.44	7.14	8.75
Tangible Book Value, 2 Yr. CAGR %	-2.15	-1.53	-14.66	-47.82	-53.01
Common Equity, 2 Yr. CAGR %	17.54	12.52	10.4	27.37	20.42
Cash From Operations, 2 Yr. CAGR %	8.65	-14.6	9.43	-3.62	-0.1
Capital Expenditures, 2 Yr. CAGR %	-4.19	15.48	5.98	-10.91	9.59
Levered Free Cash Flow, 2 Yr. CAGR %	5.66	-24.23	10.77	70.27	2.48
Unlevered Free Cash Flow, 2 Yr. CAGR %	4.3	-21.78	10.8	61.91	1.52
Dividend Per Share, 2 Yr. CAGR %	1.28	1.01	1	0.99	0.98
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.18	6.04	8.08	-0.68	1.04
Gross Profit, 3 Yr. CAGR %	5	5.3	7.58	0.16	3.73
EBITDA, 3 Yr. CAGR %	10.58	9.04	11.19	0.58	4.19
EBITA, 3 Yr. CAGR %	11.61	9.6	12.03	0.47	4.05
EBIT, 3 Yr. CAGR %	13.29	10.24	12.97	-0.51	3.13
Earnings From Cont. Operations, 3 Yr. CAGR %	23.88	16.26	15.64	7.6	3.5
Net Income, 3 Yr. CAGR %	25.37	16.26	15.64	33.89	0.89
Normalized Net Income, 3 Yr. CAGR %	16.31	11.91	14.44	0.21	5.33
Diluted EPS Before Extra, 3 Yr. CAGR %	25.78	17.19	16.96	9.24	4.97
Accounts Receivable, 3 Yr. CAGR %	3.07	7.44	8	0.43	-2.7
Inventory, 3 Yr. CAGR %	16.73	19.24	13.6	-1.31	-2.34
Net Property, Plant and Equip., 3 Yr. CAGR %	11.78	6.42	5.17	2.03	3.91
Total Assets, 3 Yr. CAGR %	7.54	7.92	7.43	6.34	7.2
Tangible Book Value, 3 Yr. CAGR %	-5.41	-1.67	-10.74	-35.34	-49.93
Common Equity, 3 Yr. CAGR %	14.81	12.22	14.68	18.4	19.99
Cash From Operations, 3 Yr. CAGR %	11.79	-5.19	6.55	-12.47	18.29
Capital Expenditures, 3 Yr. CAGR %	0.09	5.76	5.14	-0.77	1.43
Levered Free Cash Flow, 3 Yr. CAGR %	7.94	-11.82	4.69	15.15	29.88
Unlevered Free Cash Flow, 3 Yr. CAGR %	6.37	-10.75	4.75	14.54	25.9
Dividend Per Share, 3 Yr. CAGR %	1.55	1.19	1.01	1	0.99
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.52	4.52	3.83	1.65	3.9
Gross Profit, 5 Yr. CAGR %	5.96	3.82	3.8	2.65	5.45
EBITDA, 5 Yr. CAGR %	10.29	8.51	7.95	4.14	7.63
EBITA, 5 Yr. CAGR %	11.02	9.23	8.59	4.26	8.07
EBIT, 5 Yr. CAGR %	12.37	10.42	9.49	4.07	7.99
Earnings From Cont. Operations, 5 Yr. CAGR %	17.48	7.37	12.32	15.61	9.93
Net Income, 5 Yr. CAGR %	17.17	5.59	13.13	31.81	9.86
Normalized Net Income, 5 Yr. CAGR %	15	12.7	10.99	5.5	10.12
Diluted EPS Before Extra, 5 Yr. CAGR %	19.25	9.42	14.09	16.96	11.14
Accounts Receivable, 5 Yr. CAGR %	1.44	5.03	3.18	2.24	4.08
Inventory, 5 Yr. CAGR %	6.47	15.08	10.35	7.27	8.78
Net Property, Plant and Equip., 5 Yr. CAGR %	3.56	8.81	9.01	3.7	4.79
Total Assets, 5 Yr. CAGR %	0.56	0.44	6.29	7.61	7.96
Tangible Book Value, 5 Yr. CAGR %	-7.59	23.99	-9.23	-23.68	-34.37
Common Equity, 5 Yr. CAGR %	1.97	-0.45	13.02	18.05	16.94
Cash From Operations, 5 Yr. CAGR %	5.28	-0.73	10.84	-4.56	3.84
Capital Expenditures, 5 Yr. CAGR %	4.2	5.38	2.41	-2.15	5.86
Levered Free Cash Flow, 5 Yr. CAGR %	3.47	-11.14	9.06	11.26	1.53
Unlevered Free Cash Flow, 5 Yr. CAGR %	2.62	-10.37	8.12	10.33	1.38
Dividend Per Share, 5 Yr. CAGR %	2.96	2.01	1.33	1.11	1